Drug Supply Chain Security Act Public-Private Partnership
Sign up for Drug Supply Chain Security Act email updates
Public-Private Partnership
FDA engages with stakeholders to collaboratively secure the U.S. drug supply chain. The Partnership for DSCSA Governance is an independent, sector-neutral, non-profit organization working to support effective and efficient implementation of the DSCSA requirements for electronic, interoperable tracing and verification of prescription drugs in the U.S.
Public-private partnership membership includes a range of supply chain stakeholders including trading partners, trade or professional associations, technical experts and others.
FDA participates on the public-private partnership interoperable committee which fosters critical discussions about technical challenges or operational issues faced by trading partners and others. These collaborative efforts support implementation of the enhanced drug distribution security requirements, for tracing products at the package level.
These collaborative efforts help improve the integrity of the drug supply by enhancing FDA’s ability to:
- prevent harmful drugs from entering the supply chain
- detect harmful drugs before they enter the supply chain or once they are in distribution
- respond rapidly and effectively when harmful drugs are found